Bruker Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Bruker Corp 公司

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp簡介



公司代碼BRKR

公司名稱Bruker Corp

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

員工數量11396

證券類型Ordinary Share

年結日Aug 04

公司地址40 Manning Rd

城市BILLERICA

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編01821-3915

電話19786633660

網址https://www.bruker.com/

公司代碼BRKR

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

Bruker Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

-0.02%

Mr. Richard A. Packer

Independent Director

89.17K

-1.37%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

84.15K

-13.33%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

56.19K

-24.79%

Mr. John A. Ornell, CPA

Independent Director

35.21K

-3.47%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

30.94K

-15.02%

Dr. Hermann Fritz Requardt, Ph.D.

Independent Director

26.45K

-4.62%

Ms. Adelene Q. Perkins

Independent Director

24.62K

-4.96%

Dr. Cynthia M. Friend, Ph.D.

Independent Director

18.02K

-6.78%

Ms. Bonnie H. Anderson

Independent Director

13.33K

-9.17%

名稱

名稱/職務

職務

持股

持股變動

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

-0.02%

Mr. Richard A. Packer

Independent Director

89.17K

-1.37%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

84.15K

-13.33%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

56.19K

-24.79%

Mr. John A. Ornell, CPA

Independent Director

35.21K

-3.47%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

30.94K

-15.02%

收入明細

單位: USD更新時間: 4月6日週一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Product

2.77B

80.50%

Product And Service Other

670.10M

19.50%

Service and other revenue

670.10M

19.50%

地區USD

名稱

營收

佔比

Rest of Europe

950.20M

27.65%

United States

891.30M

25.94%

Rest of Asia Pacific

552.60M

16.08%

China

475.80M

13.85%

Germany

297.00M

8.64%

Other

269.60M

7.85%

業務

地區

業務USD

名稱

營收

佔比

Product

2.77B

80.50%

Product And Service Other

670.10M

19.50%

Service and other revenue

670.10M

19.50%

股東統計

更新時間: 5月11日週一

持股股東

股東類型

持股股東

佔比

Laukien (Frank H)

26.54%

Orbis Investment Management Ltd.

10.60%

Fidelity Management & Research Company LLC

8.45%

Pallas Capital Advisors LLC

6.23%

BlackRock Institutional Trust Company, N.A.

6.19%

其他

41.99%

持股股東

佔比

Laukien (Frank H)

26.54%

Orbis Investment Management Ltd.

10.60%

Fidelity Management & Research Company LLC

8.45%

Pallas Capital Advisors LLC

6.23%

BlackRock Institutional Trust Company, N.A.

6.19%

其他

41.99%

股東類型

持股股東

佔比

Investment Advisor

50.84%

Investment Advisor/Hedge Fund

27.99%

Individual Investor

26.97%

Hedge Fund

8.83%

Research Firm

1.99%

Pension Fund

1.24%

Private Equity

0.37%

Bank and Trust

0.35%

Insurance Company

0.21%

機構持股



更新時間: 4月5日週日

報告期間

機構數

持股數

持股佔比

持股變動

2026Q1

929

139.65M

91.74%

-14.82M

2025Q4

887

137.27M

94.12%

+111.45K

2025Q3

908

137.16M

94.45%

+8.73M

2025Q2

904

127.18M

89.58%

+1.13M

2025Q1

886

125.13M

85.85%

-5.11M

2024Q4

855

125.47M

82.99%

+4.02M

2024Q3

812

120.93M

80.76%

+2.25M

2024Q2

782

118.65M

76.64%

+5.15M

2024Q1

766

113.09M

82.81%

-916.64K

2023Q4

748

112.27M

83.16%

-472.55K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Laukien (Frank H)

40.41M

26.55%

+31.93K

+0.08%

Aug 15, 2025

Orbis Investment Management Ltd.

16.13M

10.6%

+1.22M

+8.21%

Feb 28, 2026

Fidelity Management & Research Company LLC

12.87M

8.45%

+1.44M

+12.65%

Dec 31, 2025

Pallas Capital Advisors LLC

9.48M

6.23%

+114.00

+0.00%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

9.42M

6.19%

+199.52K

+2.16%

Dec 31, 2025

State Street Investment Management (US)

3.83M

2.52%

+91.71K

+2.45%

Dec 31, 2025

T. Rowe Price Investment Management, Inc.

3.19M

2.1%

-3.19M

-50.01%

Dec 31, 2025

Sculptor Capital Management, Inc

3.00M

1.97%

-74.80K

-2.43%

Dec 31, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

First Trust NYSE Arca Biotechnology Index Fund

3.71%

ProShares Nanotechnology ETF

3.34%

State Street SPDR S&P Kensho Future Security ETF

1.27%

Ballast Small/Mid Cap ETF

1.13%

AB Disruptors ETF

0.63%

Invesco NASDAQ Future Gen 200 ETF

0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

0.57%

iShares Health Innovation Active ETF

0.4%

iShares Biotechnology ETF

0.36%

JPMorgan Active Small Cap Value ETF

0.31%

First Trust NYSE Arca Biotechnology Index Fund

佔比3.71%

ProShares Nanotechnology ETF

佔比3.34%

State Street SPDR S&P Kensho Future Security ETF

佔比1.27%

Ballast Small/Mid Cap ETF

佔比1.13%

AB Disruptors ETF

佔比0.63%

Invesco NASDAQ Future Gen 200 ETF

佔比0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

佔比0.57%

iShares Health Innovation Active ETF

佔比0.4%

iShares Biotechnology ETF

佔比0.36%

JPMorgan Active Small Cap Value ETF

佔比0.31%

分紅派息



近5年累計派現 113.60M 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Mar 04, 2026

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Apr 07, 2026 going ex on Mar 23, 2026

Mar 23, 2026

Apr 07, 2026

Mar 23, 2026

Nov 04, 2025

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025

Dec 08, 2025

Jan 02, 2026

Dec 08, 2025

Aug 12, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025

Sep 23, 2025

Oct 03, 2025

Sep 23, 2025

May 15, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025

Jun 16, 2025

Jun 27, 2025

Jun 16, 2025

Feb 21, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025

Mar 17, 2025

Mar 28, 2025

Mar 17, 2025

Nov 18, 2024

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024

Dec 02, 2024

Dec 16, 2024

Dec 02, 2024

Aug 14, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Sep 16, 2024

Aug 30, 2024

May 15, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jun 17, 2024

Jun 03, 2024

Feb 16, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Mar 15, 2024

Feb 29, 2024

Nov 20, 2023

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023

Dec 01, 2023

Dec 15, 2023

Nov 30, 2023

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據